Repetitiv transcranial magnetic stimulation in nicotine dependence;Transkranielle magnetstimulation bei nikotinabhängigkeit

Psychiatrische Praxis, Supplement

Volumn 30, Issue 2, 2003, Pages

  Johann, Monika ^a   Wiegand, Rainer ^a   Kharraz, Alexander ^a   Bobbe, Gabriela ^a   Sommer, Gabriele ^a   Hajak, Göran ^a   Wodarz, Norbert ^a   Eichhammer, Peter ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ADULT; AGED; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; EVALUATION; HUMAN; INDIVIDUALITY; NEUROMODULATION; PATIENT ATTITUDE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REWARD; SMOKING; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME;

EID: 0037774746     PISSN: 16118332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Kraus L, Augustin R. Repräsentativerhebung zum Gebrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland 2000. Sucht 2001; 47 (Sonderheft 1): 51-58
2. Batra A. Fagerström K-O. Neue Aspekte der Nikotinabhängigkeit und Raucherentwöhnung. Sucht 1997; 43: 277-282
3. Breslau N, Johnson EO, Hiripi E, Kessler R. Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Archives of General Psychiatry 2001; 58 (9): 810-816
4. Welte R, Konig H, Leidl R. The costs of health damage and productivity losses attributable to cigarette smoking in Germany. European Journal of Public Health 2000; 10: 31-38
5. Pelka RB. Rauchen und Mortalität. Evaluation statistischer Analysen der Kausalität. Versicherungsmedizin 2000; 52 (4): 171-178
6. John U, Hanke M. Tabakrauch-attributable Mortalität in den deutschen Bundesländern. Gesundheitswesen 2001; 63 (6): 363-369
7. Jorenby DE. New developments in approaches to smoking cessation. Curr Opin Pulm Med 1998; 4 (2): 103-106
8. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85 (14): 5274-5278
9. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 2000; 393 (1-3): 295-314
10. Soderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behavioural Brain Research 2000; 113 (1-2): 85-96
11. Mansvelder HD, Keath JR, McGehee DS. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 2002; 33 (6): 905-919
12. Jarvic M, Madsen D, Olmstead R, Iwamoto-Schaap P, Elins J, Benowitz N. Nicotine blood levels and subjective craving for cigarettes. Pharmocol Biochem Behav 2000; 66 (3): 553-558
13. Eichhammer P, Kharraz A, Wiegand R, Langguth B, Frick U, Aigner JM, Hajak G. Sleep Deprivation in Depression: Stabilizing Antidepressant Effects by Repetitiv Transcranial Magnetic Stimulation. Life Sciences, in press
14. Keck ME, Sillaber I, Ebner K, Welt T, Toschi N, Kaehler ST, Singewald N, Philippu A, Elbel GK, Wotjak CT, Holsboer F, Landgraf R, Engelmann M. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur J Neurosci 2000; 12: 3713-3720
15. Post A, Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatr Res 2001; 35 (4): 193-215
16. Lisanby SH, Gutman D, Luber B, Schroeder C, Sackeim HA. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biological Psychiatry 2001; 49 (5): 460-463
17. Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB. Gender differences in smoking cessation. J Consult Clin Psychol 1999; 67 (4): 555-562